Accession Number: | 0001615219-22-000010 |
Date: | 2022-01-20 |
Issuer: | SALARIUS PHARMACEUTICALS, INC. (SLRX) |
Original Submission Date: |
LIEBER JONATHAN I
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOMBE BLVD., SUITE X
HOUSTON, TX 77021
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.48 | 2022-01-20 | deemed execution date | A | 30,000 (a) | 2023-02-19 | 2032-01-19 | common stock 30,000 | $0.48 | 30,000 | direct |
ID | footnote |
---|